Roche Holding AG
- Country
- ๐จ๐ญSwitzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 528
- Registration Number
- NCT00002117
- Locations
- ๐บ๐ธ
Intergrated Care Ctr, Atlanta, Georgia, United States
๐บ๐ธVeterans Administration Med Ctr, Washington, District of Columbia, United States
๐บ๐ธWashington Univ, St. Louis, Missouri, United States
Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 500
- Registration Number
- NCT00017784
- Locations
- ๐บ๐ธ
Retina - Vitreous Associates Med Group, Beverly Hills, California, United States
๐บ๐ธSanta Clara Valley Med Ctr, San Jose, California, United States
๐บ๐ธQuest Clinical Research, San Francisco, California, United States
Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddC
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-03-01
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 300
- Registration Number
- NCT00001040
- Locations
- ๐บ๐ธ
Stanford Univ Med Ctr, Stanford, California, United States
๐บ๐ธUniv of Colorado Health Sciences Ctr, Denver, Colorado, United States
๐บ๐ธBellevue Hosp / New York Univ Med Ctr, New York, New York, United States
A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Hoffmann-La Roche
- Registration Number
- NCT00002377
- Locations
- ๐บ๐ธ
Univ of California / San Diego / Dept of Pediatrics, La Jolla, California, United States
๐บ๐ธSt Luke's - Roosevelt Hosp Ctr / Div of Infect Dis, New York, New York, United States
๐บ๐ธNew York Hosp - Cornell Med Ctr, New York, New York, United States
A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Registration Number
- NCT00002314
- Locations
- ๐บ๐ธ
CARE Ctr / UCLA Med Ctr, Los Angeles, California, United States
๐บ๐ธNew England Deaconess Hosp, Boston, Massachusetts, United States
T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2016-02-15
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 52
- Registration Number
- NCT00022763
- Locations
- ๐บ๐ธ
Children's Hosp Los Angeles, Los Angeles, California, United States
๐บ๐ธNew York Hosp - Cornell / Program for Children with AIDS, New York, New York, United States
๐บ๐ธBronx Lebanon Hosp Ctr, Bronx, New York, United States
A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 30
- Registration Number
- NCT00002190
- Locations
- ๐บ๐ธ
Davies Med Ctr / c/o HIV Institute, San Francisco, California, United States
๐บ๐ธColumbia Presbyterian Med Ctr, New York, New York, United States
๐บ๐ธPacific Oaks Med Group / Rsch & Scientific Investigation, Sherman Oaks, California, United States
A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT)
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Registration Number
- NCT00002279
- Locations
- ๐บ๐ธ
Hoffmann - La Roche Inc, Nutley, New Jersey, United States
An Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of Dideoxycytidine (ddC) in Patients With AIDS or Advanced ARC Who Previously Demonstrated Intolerance to Zidovudine (AZT) in Protocol N3300 or N3492
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Registration Number
- NCT00002265
- Locations
- ๐บ๐ธ
Dr Robert Swartz, Fort Myers, Florida, United States
๐บ๐ธAIDS Research Consortium of Atlanta, Atlanta, Georgia, United States
๐บ๐ธMed Service, Miami, Florida, United States
A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment
- Conditions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 3000
- Registration Number
- NCT00002334
- Locations
- ๐บ๐ธ
N Texas Ctr for AIDS & Clin Rsch, Dallas, Texas, United States
๐บ๐ธCook County Hosp, Chicago, Illinois, United States
๐บ๐ธRespiratory Associates, Corpus Christi, Texas, United States